The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
1 tablet contains 0.2 g of amiodarone hydrochloride, 0.1 g of thiotriazoline.
Prevention of recurrences of life-threatening ventricular tachycardia or ventricular fibrillation, symptomatic ventricular tachycardia; supraventricular tachycardia; heat rhythm disorders in case of resistance to or contraindication of other treatments; heart rhythm disorders attributable to WPW syndrome.Treatment of supraventricular tachycardia to slow down the heart rate or to restore the sinus rhythm in cases of atrial fibrillation and atrial flutter.
The medication is recommended for patients with ischemic heart disease and/or impaired left ventricular function for managing documented supraventricular tachycardia to control the heart rate in case of atrial fibrillation and atrial flutter.
If you have information about any adverse effects or other drug-related problems, please fill in the form